Apollomics Inc. (APLM)
NASDAQ: APLM
· Real-Time Price · USD
5.51
-0.40 (-6.77%)
At close: Aug 15, 2025, 3:55 PM
5.79
5.05%
After-hours: Aug 15, 2025, 04:31 PM EDT
-6.77% (1D)
| Bid | 5.51 |
| Market Cap | 6.08M |
| Revenue (ttm) | 2.27M |
| Net Income (ttm) | -57.11M |
| EPS (ttm) | -52.8 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -0.05 |
| Analyst | Buy |
| Ask | 6.77 |
| Volume | 10,879 |
| Avg. Volume (20D) | 28,154 |
| Open | 5.79 |
| Previous Close | 5.91 |
| Day's Range | 5.40 - 5.85 |
| 52-Week Range | 4.47 - 36.00 |
| Beta | 0.91 |
About APLM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APLM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-10.58%
Apollomics shares are trading lower. The company r...
Unlock content with
Pro Subscription
4 months ago
-18.53%
Apollomics shares are trading higher after the company announced a development and commercialization agreement for Vebreltinib.
